Published • loading... • Updated
WuXi Biologics Receives Double Honors at 2026 HERA for ESG Reporting and Environmental Excellence
- WuXi Biologics received two Grand Awards at the ninth Hong Kong ESG Reporting Awards: Best ESG Report and Excellence in Environmental Positive Impact.
- The Hong Kong ESG Reporting Awards recognize sustainability reporting and environmental, social, and governance practices, including carbon neutrality and workplace well-being.
- WuXi Biologics was selected from 120 entries and was the only pharmaceutical company to receive a Grand Award that year.
- In 2025, the Science Based Targets initiative validated WuXi Biologics’ greenhouse gas reduction targets for Scope 1, 2, and 3 emissions, aligned with a 1.5°C pathway.
Insights by Ground AI
30 Articles
30 Articles
The Paintsville Herald+29 Reposted by 29 other sources
WuXi Biologics Receives Double Honors at 2026 HERA for ESG Reporting and Environmental Excellence
HONG KONG, Nov. 3, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced it received two Grand Awards at the ninth Hong Kong ESG Reporting Awards (HERA), winning Best ESG Report…
Coverage Details
Total News Sources30
Leaning Left5Leaning Right4Center18Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 18%
C 67%
15%
Factuality
To view factuality data please Upgrade to Premium
